Menu

CRISPR Patent Dispute Heard in Federal Court

In an ongoing legal battle, the University of California, Berkeley has challenged the Broad Institute’s patent claims on the gene editing technology.

May 1, 2018
Jim Daley

ISTOCK, MICHAEL CHODYRA

Lawyers for the Broad Institute of MIT and Harvard and the University of California, Berkeley, traded oral arguments in the US Court of Appeals for the Federal Circuit in Washington on Monday (April 30). It is the latest round litigation of an ongoing patent dispute. The Broad Institute holds patents on the gene editing technology known as CRISPR, and attorneys for UC Berkeley have been challenging the claim for more than a year.  

See “UC Berkeley: Patent Office ‘Ignored Key Evidence’

“UC came into this argument from a tough spot, and I doubt that oral arguments from either side moved the needle much,” patent attorney Michael Stramiello tells STAT

UC Berkeley filed a patent application based on its work with CRISPR in May 2012, and the Broad Institute followed suit in December of that year. In April 2014, the Broad Institute was granted the first of several patents for its use of CRISPR, and attorneys for UC Berkeley quickly contested it with the US Patent and Trademark Office. The Patent Trial and Appeal Board (PTAB) ruled in favor of the Broad Institute in February 2017, saying its patents present “no interference of fact,” meaning they are sufficiently distinct from those applied for by UC Berkeley that they should not be overturned.  

See “Flux and Uncertainty in the CRISPR Patent Landscape

On Monday, lawyers for UC Berkeley argued that the PTAB made a “legal error” in that ruling. They argued that the appeals court should either reverse the board’s decision or send it back to the PTAB for further consideration.

According to Reuters, one of the three judges hearing the case says she will probably side with the PTAB and uphold its ruling. The two others did not indicate how they would rule.

In a statement issued Monday, UC general counsel and vice president for legal affairs Charles Robinson says, “[w]e presented compelling arguments today that the PTAB committed several legal errors, including disregarding Supreme Court and Federal Circuit precedent. Based on the questioning today, we are optimistic that the court has serious doubts about several aspects of the PTAB’s decision.”

Jacob Sherkow, a visiting scholar at Stanford Law School in Palo Alto, California, who was not involved in the case, thought otherwise. He tells Science that “UC did the best they could with the cards they were dealt, but it’s still not looking great for [them].”

See “Berkeley CRISPR Inventors Get Another Important European Patent

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Enabling Genomics-Guided Precision Medicine

Enabling Genomics-Guided Precision Medicine

Download this eBook from Qiagen to learn more about the promise of precision medicine and how QCITM Interpret can help deliver better care with better knowledge.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Download this application note from ACEA Biosciences, Inc., to find out how to perform an immunophenotypic analysis of a human blood sample utilizing 13 fluorescent markers using a compact benchtop flow cytometer equipped with 3 lasers!